Qaytona is free while it's in beta — Get started

Ingredients

N-Acetyl Glucosamine

N-acetylglucosamine · N-acetyl-D-glucosamine

Snapshot

IndicationsContraindications
  • Knee osteoarthritis, combination1
  • Cartilage turnover markers2, 3
  • Joint health in healthy adults2, 3
  • Inpatient COVID-19 outcomes4
  • Shellfish allergy5
  • Pregnancy or lactation5

N-acetylglucosamine is an amino sugar that serves as a building block of the glycosaminoglycans in cartilage and joint fluid, and oral supplementation aims to support cartilage turnover.2 It is taken mainly for knee osteoarthritis, often combined with Boswellia serrata and ginger, and for cartilage health in adults without arthritis2. Middle-aged and older adults with joint symptoms are the typical users. Online patient reports also describe use for anxiety.

Human research is limited to about seven small trials, mostly in osteoarthritis and cartilage metabolism. In a 2016 registry study, a combination with Boswellia serrata and ginger was followed by improved function and pain-free walking distance in knee osteoarthritis1. One randomized placebo-controlled trial in healthy adults found lower collagen degradation relative to synthesis markers, including in those with impaired cartilage metabolism2. A 2021 observational cohort of hospitalized adults with coronavirus disease 2019 (COVID-19) found shorter stays and fewer intensive care admissions than a retrospective control group. Many products list N-acetylglucosamine, mostly as capsules and powders, alone or in joint formulas; see Form comparison.

Several United States (US) product labels carry a shellfish allergy warning and some declare shellfish as an ingredient5. Per US product labels, patients taking warfarin or heparin are directed to consult a health care professional before use5.

Last updated October 18, 2026. Read how we make monographs.

In the full monograph

24 sources, 15 studies

  • When to useThe situations practitioners use it for, each with the reason and the study behind it.
  • SafetyWho should avoid it, who needs extra care, and the side effects reported in studies.
  • InteractionsThe medicines and supplements it interacts with, the effect of each, and what labeling says to watch.
  • Protocol notesThe doses used in studies, how and when they were taken, and how the forms on the market compare.
  • How it worksWhat it is and how it works in the body, in plain terms.
  • Published studiesThe studies behind each use, popular claims checked against them, and trials still under way.
  • Word of mouthWhat patients and practitioners report online, kept separate from the clinical evidence.
  • Clinical perspectiveA closing read of where the evidence is solid, where it is thin, and what has not been studied.

Sources

  1. 1Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study.pubmed.ncbi.nlm.nih.govBolognesi, Belcaro, Feragalli et al. · European review for medical and pharmacological sciences · 2016 · Pubmed
  2. 2Evaluation of the effect of N-acetyl-glucosamine administration on biomarkers for cartilage metabolism in healthy individuals without symptoms of arthritis: A randomized double-blind placebo-controlled clinical study.pubmed.ncbi.nlm.nih.govTomonaga, Watanabe, Fukagawa et al. · Experimental and therapeutic medicine · 2016 · Pubmed
  3. 3Effect of N-acetylglucosamine administration on cartilage metabolism and safety in healthy subjects without symptoms of arthritis: A case report.pubmed.ncbi.nlm.nih.govKubomura, Ueno, Yamada et al. · Experimental and therapeutic medicine · 2017 · Pubmed
  4. 4An observational cohort study to assess N-acetylglucosamine for COVID-19 treatment in the inpatient setting.pubmed.ncbi.nlm.nih.govHassan · Annals of medicine and surgery (2012) · 2021 · Pubmed
  5. 5US product labelsdsld.od.nih.govWarnings printed on US dietary supplement labels with this ingredient, from the NIH Office of Dietary Supplements' Dietary Supplement Label Database (DSLD). Manufacturers' precautions, not evidence of harm